Integration of Molecular Imaging and Biosensors for Disease Diagnosis
DOI:
https://doi.org/10.54097/37wg4078Keywords:
Biosensor, molecular Imaging, biosensor-molecular Imaging Interaction.Abstract
Molecular imaging and biosensors are two complementary ways in modern biomedical diagnostics. Molecular imaging enables real-time visualization of molecular and cellular processes in vivo with spatial resolution, while biosensors provide rapid and highly sensitive quantitative detection of biomarkers in body fluids and tissues. The combined application of these two technologies has great potential in disease detection, particularly in early cancer screening, neurological disorders, and infectious disease diagnosis. Clinicians can achieve a more comprehensive understanding of disease progression by combining the spatial distribution information obtained from imaging with the temporal and quantitative signals obtained from biosensors. This integration enables the early prevention of disease deterioration. This review summarizes the fundamental principles of molecular imaging and biosensors, and their advantages and disadvantages are comparatively analyzed, explores their clinical applications and integration strategies, emphasizes the approaches of system integration and the methods of data and signal fusion, and discusses the challenges and future perspectives in clinical translation.
Downloads
References
[1] K.-H. Jung and K.-H. Lee, "Molecular Imaging in the Era of Personalized Medicine," Journal of Pathology and Translational Medicine, vol. 49, no. 1, pp. 5-12, 2015.
[2] S. P. Rowe and M. G. Pomper, "Molecular imaging in oncology: Current impact and future directions," CA: A Cancer Journal for Clinicians, vol. 72, no. 4, pp. 333-352, 2021.
[3] V. Ntziachristos, "Going deeper than microscopy: the optical imaging frontier in biology," Nature Methods, vol. 7, no. 8, pp. 603-614, 2010.
[4] V. P. B. Grover, J. M. Tognarelli, M. M. E. Crossey, I. J. Cox, S. D. Taylor-Robinson, and M. J. W. McPhail, "Magnetic Resonance Imaging: Principles and Techniques: Lessons for Clinicians," Journal of Clinical and Experimental Hepatology, vol. 5, no. 3, pp. 246-255, 2015.
[5] J. E. Aldrich, "Basic physics of ultrasound imaging," Critical Care Medicine, vol. 35, no. Suppl, pp. S131-S137, 2007.
[6] R. Weissleder and M. J. Pittet, "Imaging in the era of molecular oncology," Nature, vol. 452, no. 7187, pp. 580-589, 2008.
[7] J. Trotter et al., "Positron Emission Tomography (PET)/Computed Tomography (CT) Imaging in Radiation Therapy Treatment Planning: A Review of PET Imaging Tracers and Methods to Incorporate PET/CT," Adv Radiat Oncol, vol. 8, no. 5, p. 101212, Sep-Oct 2023.
[8] M. Palihati, J. P. Das, R. Yeh, and K. Capaccione, "Emerging PET Imaging Agents and Targeted Radioligand Therapy: A Review of Clinical Applications and Trials," Tomography, vol. 11, no. 8, Jul 28 2025.
[9] D. Albano, A. Rizzo, A. Guarneri, L. Leccisotti, C. Rodella, and G. Treglia, "Emerging PET-radiotracers in cardiovascular, neuro-inflammation, lung and rheumatological diseases: a narrative review," EJNMMI Rep, vol. 9, no. 1, p. 28, Aug 11 2025.
[10] A. P. F. Turner, "Biosensors: sense and sensibility," Chemical Society Reviews, vol. 42, no. 8, 2013.
[11] D.-E. Lee, H. Koo, I.-C. Sun, J. H. Ryu, K. Kim, and I. C. Kwon, "Multifunctional nanoparticles for multimodal imaging and theragnosis," Chem. Soc. Rev., vol. 41, no. 7, pp. 2656-2672, 2012.
[12] J. Quinchia, D. Echeverri, A. F. Cruz-Pacheco, M. E. Maldonado, and J. Orozco, "Electrochemical Biosensors for Determination of Colorectal Tumor Biomarkers," Micromachines (Basel), vol. 11, no. 4, Apr 14 2020.
[13] V. N. Palakollu, Y. Veera Manohara Reddy, M. I. Shekh, S. V. P. Vattikuti, J. Shim, and R. Karpoormath, "Electrochemical immunosensing of tumor markers," Clin Chim Acta, vol. 557, p. 117882, Apr 15 2024.
[14] S. Basu, A. Hendler-Neumark, and G. Bisker, "Monitoring Enzyme Activity Using Near-Infrared Fluorescent Single-Walled Carbon Nanotubes," ACS Sens, vol. 9, no. 5, pp. 2237-2253, May 24 2024.
[15] J. Wang, "Electrochemical Glucose Biosensors," Chemical Reviews, vol. 108, no. 2, pp. 814-825, 2007.
[16] Y. Guo and L. Feng, "Highly Sensitive Detection of Carcinoembryonic Antigen via an Electrochemical Platform Fabricated by AuNPs/Streptavidin/Reduced Graphene Oxide," Frontiers in Chemistry, vol. 10, 2022.
[17] M. Labib, E. H. Sargent, and S. O. Kelley, "Electrochemical Methods for the Analysis of Clinically Relevant Biomolecules," Chemical Reviews, vol. 116, no. 16, pp. 9001-9090, 2016.
[18] E. M. McBride et al., "Paper spray ionization: Applications and perspectives," TrAC Trends in Analytical Chemistry, vol. 118, pp. 722-730, 2019/09/01/ 2019.
[19] J. Kim, A. S. Campbell, B. E.-F. de Ávila, and J. Wang, "Wearable biosensors for healthcare monitoring," Nature Biotechnology, vol. 37, no. 4, pp. 389-406, 2019.
[20] S. A. Toms, W.-C. Lin, R. J. Weil, M. D. Johnson, E. D. Jansen, and A. Mahadevan-Jansen, "Intraoperative Optical Spectroscopy Identifies Infiltrating Glioma Margins with High Sensitivity," Operative Neurosurgery, vol. 57, pp. 382-391, 2005.
[21] G. Seo et al., "Rapid Detection of COVID-19 Causative Virus (SARS-CoV-2) in Human Nasopharyngeal Swab Specimens Using Field-Effect Transistor-Based Biosensor," ACS Nano, vol. 14, no. 4, pp. 5135-5142, 2020.
[22] L. Wang and C. Li, "pH responsive fluorescence nanoprobe imaging of tumors by sensing the acidic microenvironment," Journal of Materials Chemistry, vol. 21, no. 40, 2011.
[23] R. Weissleder and M. Nahrendorf, "Advancing biomedical imaging," Proceedings of the National Academy of Sciences, vol. 112, no. 47, pp. 14424-14428, 2015.
[24] J. V. Jokerst and S. S. Gambhir, "Molecular Imaging with Theranostic Nanoparticles," Accounts of Chemical Research, vol. 44, no. 10, pp. 1050-1060, 2011.
[25] R. Weissleder, "Molecular Imaging in Cancer," Science, vol. 312, no. 5777, pp. 1168-1171, 2006.
[26] A. V. Leopold, D. M. Shcherbakova, and V. V. Verkhusha, "Fluorescent Biosensors for Neurotransmission and Neuromodulation: Engineering and Applications," Frontiers in Cellular Neuroscience, vol. 13, 2019.
[27] M. Banakar et al., "Electrochemical Biosensors for Pathogen Detection: An Updated Review," Biosensors, vol. 12, no. 11, 2022.
[28] M. A. Eckert et al., "Novel Molecular and Nanosensors for In Vivo Sensing," Theranostics, vol. 3, no. 8, pp. 583-594, 2013.
[29] S. R. Stahlschmidt, B. Ulfenborg, and J. Synnergren, "Multimodal deep learning for biomedical data fusion: a review," Briefings in Bioinformatics, vol. 23, no. 2, 2022.
[30] S. Han, T. Ninjbadgar, M. Kang, C. Kim, and J. Kim, "Recent Advances in Photoacoustic Agents for Theranostic Applications," Nanomaterials, vol. 13, no. 4, 2023.
[31] H. Tong, K. Lou, and W. Wang, "Near-infrared fluorescent probes for imaging of amyloid plaques in Alzheimer׳s disease," Acta Pharmaceutica Sinica B, vol. 5, no. 1, pp. 25-33, 2015.
[32] E. Cesewski and B. N. Johnson, "Electrochemical biosensors for pathogen detection," Biosensors and Bioelectronics, vol. 159, 2020.
[33] E. Blanco, H. Shen, and M. Ferrari, "Principles of nanoparticle design for overcoming biological barriers to drug delivery," Nature Biotechnology, vol. 33, no. 9, pp. 941-951, 2015, doi: 10.1038/nbt.3330.
[34] A. M. Smith, M. C. Mancini, and S. Nie, "Second window for in vivo imaging," Nature Nanotechnology, vol. 4, no. 11, pp. 710-711, 2009.
[35] J. Wang, "Electrochemical biosensors: Towards point-of-care cancer diagnostics," Biosensors and Bioelectronics, vol. 21, no. 10, pp. 1887-1892, 2006.
[36] M. A. Dobrovolskaia and S. E. McNeil, “Immunological properties of engineered nanomaterials,” Nature Nanotechnology, vol. 2, pp. 469–478, Aug. 2007.
[37] Y. Tian, L. Du, P. Zhu, Y. Chen, W. Chen, C. Wu, P. Wang, and P. Wang, “Recent progress in micro/nano biosensors for shellfish toxin detection,” Biosensors and Bioelectronics, vol. 161, p. 112899, 2020.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
